Search

Radcliffe Institute-Sponsored Special Workshop on the Development of ‘ The Human Glycome Project (HuGlyP)’, a groundbreaking workshop that brought together leaders in the field of glycosciences and related areas to initiate the conversation on how to define the Human Glycome https://www.radcliffe...

The Author File: Richard D. Cummings A bleaching method for glycobiology and some impromptu fund-raising at the piano. By: Vivien Marx; Nature Methods, 2016, Vol.13(6), p.461 PDF available upon request.

In February 2016, Reza Dana, MD, MPH, MSc, Vice Chair for Academic Programs for the Harvard Medical School (HMS) Department of Ophthalmology, and Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear, was elected to Academia Ophthalmologica Internationalis (AOI), one of...

Another one for the books, congratulations to Dr. Matyal and team for publishing a review article about neuropeptide Y in the European Journal of Pharmacology earlier this year!

Findings could eventually lead to first non-surgical therapies and treatments for FECD. BOSTON -- Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs’ Endothelial...

Congratulations to the Valve Research Group for their wonderful posters and presentations at the 38th Annual SCA Conference! Of note were the five out of fifteen 'Best of Meeting Abstract Presentations' that were authored and presented by our very own Ziyad Knio, Jelliffe Jeganathan and Rabya Saraf.

A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of...

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to...

Dear Friends,It has been an eventful year moving from the University of Alberta in Canada to the Complex Carbohydrate Research Center at the University of Georgia in the USA and planning a really exciting program for the 2016 Society for Glycobiology Annual Meeting!I would like to formally invite...

Boston, Mass. — Lotfi B. Merabet, PhD, OD, MPH , an optometrist and vision researcher at Massachusetts Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School, is the 2016 recipient of the Low Vision Research Award from Research to Prevent Blindness (RPB) and the Lions...